hexamethylene bisacetamide has been researched along with cholecalciferol in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bacher, M; Kiefer, P; Pflüger, KH | 1 |
| Chen, A; Hellinger, N; Licht, JD; Scher, W; Waxman, S; Wu, Y | 1 |
| Ferrini, PR; Santini, V | 1 |
1 review(s) available for hexamethylene bisacetamide and cholecalciferol
| Article | Year |
|---|---|
Differentiation therapy of myelodysplastic syndromes: fact or fiction?
Topics: Acetamides; Amifostine; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Arginine; Azacitidine; Butyrates; Cholecalciferol; Cytarabine; Harringtonines; Hematopoietic Cell Growth Factors; Heme; Homoharringtonine; Humans; Interferons; Myelodysplastic Syndromes; Retinoids | 1998 |
2 other study(ies) available for hexamethylene bisacetamide and cholecalciferol
| Article | Year |
|---|---|
Relationship of calcitonin mRNA expression to the differentiation state of HL 60 cells.
Topics: Acetamides; Calcitonin; Calcitonin Gene-Related Peptide; Cell Differentiation; Cell Division; Cholecalciferol; Dimethyl Sulfoxide; Gene Expression; Humans; Leukemia, Promyelocytic, Acute; Macrophages; Models, Biological; Monocytes; Phenotype; RNA, Messenger; Staining and Labeling; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured | 1994 |
Retinoic acid is required for and potentiates differentiation of acute promyelocytic leukemia cells by nonretinoid agents.
Topics: Acetamides; Butyrates; Cell Differentiation; Cholecalciferol; Cytarabine; Drug Synergism; Humans; In Vitro Techniques; Leukemia, Promyelocytic, Acute; Tretinoin; Tumor Cells, Cultured | 1994 |